4:
A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R, Golla R, Ma Z, Zhang H, O'Malley K, Lippy J, Cheng L, Mookhtiar K, Farrelly D, Zhang L, Hariharan N, Cheng PT.
Anal Biochem. 2007 Apr 15;363(2):263-74. Epub 2007 Jan 28.
PMID: 17335769 [PubMed - indexed for MEDLINE]
Related Articles
6:
Synthesis, biological evaluation, and molecular modeling investigation of new chiral fibrates with PPARalpha and PPARgamma agonist activity.
Pinelli A, Godio C, Laghezza A, Mitro N, Fracchiolla G, Tortorella V, Lavecchia A, Novellino E, Fruchart JC, Staels B, Crestani M, Loiodice F.
J Med Chem. 2005 Aug 25;48(17):5509-19.
PMID: 16107150 [PubMed - indexed for MEDLINE]
Related Articles
10:
PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK, Chae YN, Son MH, Kim SH, Kim JK, Moon HS, Park CS, Bae MH, Kim E, Han T, Choi HH, Shin YA, Ahn BN, Lee CH, Lim JI, Shin CY.
Eur J Pharmacol. 2008 Oct 24;595(1-3):119-25. Epub 2008 Aug 12.
PMID: 18727927 [PubMed - indexed for MEDLINE]
Related Articles
11:
T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties.
Li Y, Wang Z, Furukawa N, Escaron P, Weiszmann J, Lee G, Lindstrom M, Liu J, Liu X, Xu H, Plotnikova O, Prasad V, Walker N, Learned RM, Chen JL.
J Biol Chem. 2008 Apr 4;283(14):9168-76. Epub 2008 Feb 7.
PMID: 18263587 [PubMed - indexed for MEDLINE]
Related Articles
17:
Design, synthesis, and structure-activity relationship of carbamate-tethered aryl propanoic acids as novel PPARalpha/gamma dual agonists.
Kim NJ, Lee KO, Koo BW, Li F, Yoo JK, Park HJ, Min KH, Lim JI, Kim MK, Kim JK, Suh YG.
Bioorg Med Chem Lett. 2007 Jul 1;17(13):3595-8. Epub 2007 Apr 25.
PMID: 17507225 [PubMed - indexed for MEDLINE]
Related Articles
18:
A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A, Otto K, Hawkins E, Barr R, Bensch WR, Bull C, Dana S, Klausing K, Martin JA, Rafaeloff-Phail R, Rafizadeh-Montrose C, Rhodes G, Robey R, Rojo I, Rungta D, Snyder D, Wilbur K, Zhang T, Zink R, Warshawsky A, Brozinick JT.
Mol Endocrinol. 2005 Jun;19(6):1593-605. Epub 2005 Apr 14.
PMID: 15831517 [PubMed - indexed for MEDLINE]
Related Articles
20:
Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists.
Suh YG, Kim NJ, Koo BW, Lee KO, Moon SH, Shin DH, Jung JW, Paek SM, Chang DJ, Li F, Kang HJ, Le TV, Chae YN, Shin CY, Kim MK, Lim JI, Ryu JS, Park HJ.
J Med Chem. 2008 Oct 23;51(20):6318-33. Epub 2008 Oct 1.
PMID: 18826205 [PubMed - indexed for MEDLINE]
Related Articles